RELMADA THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Relmada Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2011 to Q2 2024.
  • Relmada Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.8M, a 29.8% increase year-over-year.
  • Relmada Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$86.8M, a 32.7% increase year-over-year.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$98.8M, a 37.1% increase from 2022.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$157M, a 24.9% decline from 2021.
  • Relmada Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$126M, a 112% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$86.8M -$17.8M +$7.53M +29.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$94.3M -$21.8M +$4.49M +17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$98.8M -$25.2M +$12.8M +33.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 -$112M -$22M +$17.4M +44.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$129M -$25.3M +$14.6M +36.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$144M -$26.3M +$13.4M +33.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$157M -$37.9M -$3.57M -10.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 -$153M -$39.4M +$3.19M +7.48% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$157M -$39.9M -$13.4M -50.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-08
Q1 2022 -$143M -$39.7M -$17.5M -78.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-08
Q4 2021 -$126M -$34.4M -$13.6M -65.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$112M -$42.6M -$25.7M -152% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$86.4M -$26.6M -$15.4M -139% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$71M -$22.2M -$11.5M -108% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$59.5M -$20.8M -$16.2M -359% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 -$43.2M -$16.9M -$13.2M -361% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$30M -$11.1M -$7M -170% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$23M -$10.7M -$7.99M -297% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$15M -$4.53M +$2.6M +36.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-24
Q3 2019 -$17.6M -$3.67M -$289K -8.56% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$17.3M -$4.12M -$773K -23.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$16.5M -$2.69M +$516K +16.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-08-12
Q4 2018 -$17.1M -$7.13M -$5.7M -399% Oct 1, 2018 Dec 31, 2018 10-Q 2019-05-15
Q3 2018 -$11.4M -$3.38M -$2.4M -244% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$8.96M -$3.35M -$1.72M -105% Apr 1, 2018 Jun 30, 2018 10-KT 2020-03-26
Q1 2018 -$7.24M -$3.2M -$1.22M -61.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$6.02M -$1.43M -$397K -38.5% Oct 1, 2017 Dec 31, 2017 10-Q 2019-05-15
Q3 2017 -$5.63M -$982K +$659K +40.2% Jul 1, 2017 Sep 30, 2017 10-Q 2019-05-15
Q2 2017 -$6.29M -$1.63M +$1.68M +50.8% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-28
Q1 2017 -$7.97M -$1.98M -$122K -6.55% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$7.85M -$1.03M +$1.43M +58.1% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-12
Q3 2016 -$9.28M -$1.64M -$6.3M -135% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$2.97M -$3.32M -$9.36M -155% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-28
Q1 2016 $6.39M -$1.86M +$603K +24.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $5.78M -$2.46M -$7.92M -145% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-10
Q3 2015 $13.7M $4.66M +$34.5M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$20.8M $6.04M Apr 1, 2015 Jun 30, 2015 10-K 2016-09-09
Q1 2015 -$2.46M -$8.96M -138% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 $5.46M +$10.6M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-05
Q3 2014 -$29.8M -$28.3M -1806% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q1 2014 $6.49M +$7.12M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 -$5.17M -$5.16M Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-13
Q3 2013 -$1.57M Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q1 2013 -$630K Jan 1, 2013 Mar 31, 2013 8-K 2014-05-27
Q4 2012 -$9.02K* Sep 1, 2012 Nov 30, 2012 10-Q 2014-01-13
Q3 2011 -$90* May 23, 2011 Aug 31, 2011 10-K 2013-12-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.